piperazine has been researched along with American Trypanosomiasis in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " cruzi infection after once daily oral dosing at 20, 50 and 100 mg/kg for 5 days." | 1.39 | Design, structure-activity relationship and in vivo efficacy of piperazine analogues of fenarimol as inhibitors of Trypanosoma cruzi. ( Alexander, PW; Best, WM; Charman, SA; Chatelain, E; Diao, H; Gregg, AD; Keenan, M; Kerfoot, M; Khong, A; Ryan, E; Scandale, I; Shackleford, DM; Thompson, RC; von Geldern, TW; White, KL, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Keenan, M | 1 |
| Alexander, PW | 1 |
| Diao, H | 1 |
| Best, WM | 1 |
| Khong, A | 1 |
| Kerfoot, M | 1 |
| Thompson, RC | 1 |
| White, KL | 1 |
| Shackleford, DM | 1 |
| Ryan, E | 1 |
| Gregg, AD | 1 |
| Charman, SA | 1 |
| von Geldern, TW | 1 |
| Scandale, I | 1 |
| Chatelain, E | 1 |
1 other study available for piperazine and American Trypanosomiasis
| Article | Year |
|---|---|
Design, structure-activity relationship and in vivo efficacy of piperazine analogues of fenarimol as inhibitors of Trypanosoma cruzi.
Topics: Administration, Oral; Animals; Chagas Disease; Drug Design; Humans; Mice; Piperazine; Piperazines; P | 2013 |